21-25885348-C-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000484.4(APP):​c.2212-3577G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.334 in 152,152 control chromosomes in the GnomAD database, including 8,864 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.33 ( 8864 hom., cov: 33)

Consequence

APP
NM_000484.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.713

Publications

8 publications found
Variant links:
Genes affected
APP (HGNC:620): (amyloid beta precursor protein) This gene encodes a cell surface receptor and transmembrane precursor protein that is cleaved by secretases to form a number of peptides. Some of these peptides are secreted and can bind to the acetyltransferase complex APBB1/TIP60 to promote transcriptional activation, while others form the protein basis of the amyloid plaques found in the brains of patients with Alzheimer disease. In addition, two of the peptides are antimicrobial peptides, having been shown to have bacteriocidal and antifungal activities. Mutations in this gene have been implicated in autosomal dominant Alzheimer disease and cerebroarterial amyloidosis (cerebral amyloid angiopathy). Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Aug 2014]
APP Gene-Disease associations (from GenCC):
  • Alzheimer disease type 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • cerebral amyloid angiopathy, APP-related
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • ABeta amyloidosis, Arctic type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABeta amyloidosis, dutch type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABeta amyloidosis, Iowa type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABeta amyloidosis, Italian type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABetaA21G amyloidosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABetaL34V amyloidosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset autosomal dominant Alzheimer disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.387 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
APPNM_000484.4 linkc.2212-3577G>T intron_variant Intron 17 of 17 ENST00000346798.8 NP_000475.1 P05067-1A0A140VJC8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
APPENST00000346798.8 linkc.2212-3577G>T intron_variant Intron 17 of 17 1 NM_000484.4 ENSP00000284981.4 P05067-1

Frequencies

GnomAD3 genomes
AF:
0.334
AC:
50750
AN:
152034
Hom.:
8864
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.237
Gnomad AMI
AF:
0.423
Gnomad AMR
AF:
0.296
Gnomad ASJ
AF:
0.416
Gnomad EAS
AF:
0.321
Gnomad SAS
AF:
0.300
Gnomad FIN
AF:
0.379
Gnomad MID
AF:
0.478
Gnomad NFE
AF:
0.391
Gnomad OTH
AF:
0.354
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.334
AC:
50752
AN:
152152
Hom.:
8864
Cov.:
33
AF XY:
0.331
AC XY:
24643
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.237
AC:
9821
AN:
41518
American (AMR)
AF:
0.296
AC:
4522
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.416
AC:
1446
AN:
3472
East Asian (EAS)
AF:
0.322
AC:
1659
AN:
5160
South Asian (SAS)
AF:
0.301
AC:
1451
AN:
4820
European-Finnish (FIN)
AF:
0.379
AC:
4016
AN:
10604
Middle Eastern (MID)
AF:
0.486
AC:
143
AN:
294
European-Non Finnish (NFE)
AF:
0.391
AC:
26565
AN:
67964
Other (OTH)
AF:
0.352
AC:
744
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1748
3496
5244
6992
8740
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
502
1004
1506
2008
2510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.371
Hom.:
47958
Bravo
AF:
0.321
Asia WGS
AF:
0.313
AC:
1087
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
4.2
DANN
Benign
0.49
PhyloP100
0.71
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs373521; hg19: chr21-27257660; API